Spate of Indiana firms lines up for IPOs

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

More
Stories

State's economy stuck in neutral Indictment: Durham looted Fair Finance Ballard cruises to second term City backs string of high-profile projects Manning's injury sends Colts into tailspin Downtown mall stung by loss of Nordstrom Right-to-work battle derails legislative session General Assembly overhauls K-12 education Real estate meltdown leaves developers reeling Spate of Indiana firms lines up for IPOs Rolls-Royce relocated 2,500 jobs to downtown Openings launch new era for tourism biz Patent expirations up pressure on Lilly Las Vegas crash saps IndyCar momentum

Newsmakers

Simon takes on Amazon.com Melangton Daniels White in crosshairs as reformers target IPS

High-profile Hoosier companies raced to go public in 2011, despite the topsy-turvy stock market.

The highest-profile Hoosier initial public offering was staged by Angie’s List Inc., the online provider of consumer reviews. The Indianapolis-based company raised $76 million by selling new shares, and existing stockholders raked in another $31 million by selling some of their holdings.

Investors scarfed up the shares, undeterred by the company’s deep losses and heavy spending on marketing. The stock debuted at $13 and shot as high as $18.75 before retreating to around $16.00

 The other Hoosier company to go public was West Lafayette-based Endocyte Inc., which hopes to bring an ovarian cancer drug to market. The company debuted at $6 a share in February and climbed as high as $14.80 in the summer. However, this month, the stock tumbled more than 60 percent, to $3.76, after clinical trial results showed the company’s ovarian cancer treatment led to shorter survival times than treatment with a standard cancer drug.

Other companies filed papers with the Securities and Exchange Commission to begin the process of going public. Indianapolis-based ExactTarget Inc. disclosed plans to raise $100 million in an IPO.

In addition, Allison Transmission Inc. in March said it planned to raise $750 million. It put an IPO on the back burner when markets soured, but filed papers in November to revive the process.

Pendleton-based Remy International, a maker of electrical components for vehicles, in March filed plans for a $100 million IPO. Company officials are monitoring market conditions before deciding whether to proceed.•

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In